RECALL: Qualitest Pharmaceuticals Issues Voluntary, Nationwide Retail Level Recalls

Qualitest Pharmaceuticals issued a voluntary nationwide retail level recall of butalbital, acetaminophen, and caffeine 50mg/325mg/40mg tablets, and hydrocodone bitartrate and acetaminophen 7.5mg/500mg tablets. This recall was initiated because an individual bottle of butalbital, acetaminophen, and caffeine 50mg/325mg/40mg tablets, 500 count was found incorrectly labeled with a hydrocodone bitartrate and acetaminophen 7.5mg/500mg tablets, 1000 count label, printed with Lot Number C0590909B. Lots C0390909A, C0400909A, C0410909A used the same stock inventory of labels as Lot C0590909B and are potentially impacted.

The recall includes the following products:

• Butalbital, Acetaminophen, and Caffeine Tablets, USP, 50mg/325mg/40mg, NDC 0603-2544-28 500 count, Lot Numbers C0390909A, C0400909A, C0410909A, C0590909B
• Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5mg / 500mg, NDC 0603-3882-32, 1000 count, Lot Numbers C0390909A, C0400909A, C0410909A, C0590909B

For more information call (800) 444-4011 or visit www.qualitestrx.com.